首页> 外文期刊>BMC Cancer >Study protocol for a controlled trial of an eHealth system utilising patient reported outcome measures for personalised treatment and care: PROMPT-Care 2.0
【24h】

Study protocol for a controlled trial of an eHealth system utilising patient reported outcome measures for personalised treatment and care: PROMPT-Care 2.0

机译:使用患者报告的针对个性化治疗和护理的结局指标的eHealth系统对照试验的研究方案:PROMPT-Care 2.0

获取原文
           

摘要

Routine assessment and clinical utilisation of patient-reported outcome (PRO) measures can lead to improved patient outcomes. The PROMPT-Care eHealth system facilitates PRO data capture from cancer patients, data linkage and retrieval to support clinical decisions, patient self-management, and shared care. Pilot testing demonstrated acceptability and feasibility of PROMPT-Care Version 1.0. This study aims to implement PROMPT-Care Version 2.0 and determine its efficacy in reducing emergency department (ED) presentations, and improving chemotherapy delivery and health service referrals, compared to usual care. Groups eligible to participate in the intervention arm of this controlled trial are patients receiving cancer care (including follow-up). PROMPT-Care patients will complete monthly assessments (distress, symptoms, unmet needs) until voluntary withdrawal or death. In Version 1.0, the care team accessed patients’ clinical feedback reports in ‘real time’ to guide their care, and patients received links to support their self-management, tailored to their PRO responses. Version 2.0 was extended to include: i) an additional alert system notifying the care team of ongoing unresolved clinical issues, ii) patient self-management resources, and iii) an auto-populated Treatment Summary and Survivorship Care Plan (SCP). The control population will be patients extracted from hospital databases of the general cancer patient population who were seen at the participating cancer therapy centres during the study period, with a ratio of 1:4 of intervention to control patients. A minimum sample size of 1760 (352 intervention and 1408 control) patients will detect a 14% reduction in the number of ED presentations (primary outcome) in the PROMPT-Care group compared with the control group. Intervention patients will provide feedback on system usability and value of the self-management materials; oncology staff will provide feedback on usefulness of PROMPT-Care reports, response to clinical alerts, impact on routine care, and usefulness of the SCPs; and GPs will provide feedback on the usefulness of the SCPs and attitudes towards shared-care models of survivorship care planning. This study will inform the PROMPT-Care system’s impact on healthcare utilisation and utility as an alternative model for ongoing supportive care. Australian New Zealand Clinical Trials Registry ( ACTRN12616000615482 ) on 12th May 2016 ( www.anzctr.org.au ).
机译:对患者报告的结局(PRO)措施进行常规评估和临床利用可以改善患者的结局。 PROMPT-Care eHealth系统有助于从癌症患者中获取PRO数据,进行数据链接和检索以支持临床决策,患者自我管理和共享医疗。初步测试证明了PROMPT-Care版本1.0的可接受性和可行性。这项研究旨在实施PROMPT-Care 2.0版,并确定其与常规护理相比在减少急诊科(ED)表现,改善化学疗法的交付和卫生服务转诊方面的功效。有资格参加该对照试验的干预组的人群是接受癌症治疗(包括随访)的患者。 PROMPT-Care患者将完成每月评估(痛苦,症状,未满足的需求),直到自愿退​​出或死亡。在1.0版中,护理团队“实时”访问了患者的临床反馈报告,以指导他们的护理,并且患者获得了针对其自我管理的链接,这些链接是针对PRO反应量身定制的。 2.0版进行了扩展,包括:i)额外的警报系统,用于通知护理团队当前仍未解决的临床问题; ii)患者的自我管理资源;以及iii)自动填充的治疗摘要和生存护理计划(SCP)。对照人群是在研究期间从参与研究的癌症治疗中心看过的普通癌症患者的医院数据库中提取的患者,干预与对照患者的比例为1:4。与对照组相比,在PROMPT-Care组中,最小样本量为1760名患者(352名干预者和1408名对照者)将发现ED表现(主要结局)减少14%。干预患者将提供有关系统可用性和自我管理材料价值的反馈;肿瘤学人员将提供有关PROMPT-Care报告有用性,对临床警报的响应,对常规护理的影响以及SCP有用性的反馈;全科医生将提供关于SCP的有用性以及对生存护理计划共享护理模式的态度的反馈。这项研究将告知PROMPT-Care系统作为持续支持护理的替代模型对医疗保健利用率和效用的影响。澳大利亚新西兰临床试验注册中心(ACTRN12616000615482)于2016年5月12日(www.anzctr.org.au)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号